| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 18, 2005
From the Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands (H.L.T., A.B., A.A.M.W.); Division of Cardiology, Department of Internal Medicine, National Cardiovascular Center, Suita, Osaka, Japan (W.S., T.N.); Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY (A.J.M.); and Department of Cardiology and Angiology and Leibniz Institute for Arteriosclerosis Research, University of Münster, Münster, Germany (E.S.-B.). * To whom correspondence should be addressed. E-mail: a.a.wilde{at}amc.uva.nl.
Background--The identification of the molecular-genetic substrate underlying the various forms of the congenital long-QT syndrome (LQTS) has sparked studies into possible genotype-phenotype correlations with the aim of developing genotype-tailored therapy. The onset of torsade de pointes (TdP) may differ among LQTS patients, being pause dependent in some but not all. This disparity may point to different arrhythmia mechanisms and may affect therapy strategies. We studied whether the proportion of pause-dependent TdP onset varies among LQTS genotypes. Methods and Results--We studied all LQT1 (n=10), LQT2 (n=34), and LQT3 (n=6) patients from 4 centers for whom ECGs of TdP onset were available and analyzed whether pauses preceded TdP onset (first available ECG per patient). Pauses preceded TdP significantly more often in LQT2 (68%) than in LQT1 (0%), and the interval immediately before TdP (pause interval) was significantly longer in LQT2 than in LQT1. The proportion of pause dependence in LQT3 (33%) appeared intermediate, but this group was too small for statistical analysis. Conclusions--Pause dependence of TdP onset is predominant in LQT2 but absent or rare in LQT1. It is suggested that disparities in pause dependence of TdP onset may reflect different arrhythmia mechanisms.
Revised on September 1, 2006
Accepted on September 8, 2006
Genotype-Specific Onset of Arrhythmias in Congenital Long-QT Syndrome. Possible Therapy Implications
Hanno L. Tan MD, PhD,
Related Article:
Circulation 2006 114: 2089.
This article has been cited by other articles:
![]() |
S. Kapa, D. J. Tester, B. A. Salisbury, C. Harris-Kerr, M. S. Pungliya, M. Alders, A. A.M. Wilde, and M. J. Ackerman Genetic Testing for Long-QT Syndrome: Distinguishing Pathogenic Mutations From Benign Variants Circulation, November 3, 2009; 120(18): 1752 - 1760. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, M. R. Franz, A. Bardai, and A. M. Wilde Giant T-U Waves Precede Torsades de Pointes in Long QT Syndrome A Systematic Electrocardiographic Analysis in Patients With Acquired and Congenital QT Prolongation. J. Am. Coll. Cardiol., July 7, 2009; 54(2): 143 - 149. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Johnson, N. Hofman, C. M. Haglund, G. D. Cascino, A.A.M. Wilde, and M. J. Ackerman Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy Neurology, January 20, 2009; 72(3): 224 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Viskin and A. Halkin Treating the Long-QT Syndrome in the Era of Implantable Defibrillators Circulation, January 20, 2009; 119(2): 204 - 206. [Full Text] [PDF] |
||||
![]() |
C. I. Berul Congenital Long-QT Syndromes: Who's at Risk for Sudden Cardiac Death? Circulation, April 29, 2008; 117(17): 2178 - 2180. [Full Text] [PDF] |
||||
![]() |
D. M. Roden Long-QT Syndrome N. Engl. J. Med., January 10, 2008; 358(2): 169 - 176. [Full Text] [PDF] |
||||
![]() |
I. C. Van Gelder, on behalf of the EHRA Education Committee, G. Boriani, S. Ernst, H. Heidbuchel, A. Zaza, M. Makijarvi, B. Gorenek, and C. B. Lundquist Case of polymorphic ventricular tachycardia after stroke necessitating defibrillation Europace, January 1, 2008; 10(1): 124 - 125. [Full Text] [PDF] |
||||
![]() |
L. Fabritz Drug-induced torsades de pointes -- A form of mechano-electric feedback? Cardiovasc Res, November 1, 2007; 76(2): 202 - 203. [Full Text] [PDF] |
||||
![]() |
D. J. Gallacher, A. Van de Water, H. van der Linde, A. N. Hermans, H. R. Lu, R. Towart, and P. G.A. Volders In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome Cardiovasc Res, November 1, 2007; 76(2): 247 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Passman and A. Kadish Sudden Death Prevention With Implantable Devices Circulation, July 31, 2007; 116(5): 561 - 571. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |